Identifying the key drivers of disease is critical in developing more effective therapies. Arpeggio does this by sequencing the “functional” genome. Our automated workflow for nascent RNA sequencing and open chromatin profiling makes it easy to characterize cells at unprecedented resolution.
Genomics generates massive amounts of data, making it a challenge to analyze and work with. Arpeggio has built software that automatically manages and processes genomics data using cutting-edge statistics and machine learning, all with the click of a button.Explore Our Software
Arpeggio is building a new map of the gene regulatory network. We’ve developed more sensitive transcriptomics assays and cutting-edge machine learning to understand biology at unprecedented resolution.
RNA is everywhere, but not all RNA is active. We’ve developed and scaled assays to measure active transcription, which allows us to perform compound treatments at minute resolution and identify the primary transcriptional response to any cellular perturbation.
Genomics data is large and cumbersome. We've built a new software stack that integrates directly with AWS S3. Arpeggio's software can rapidly analyze thousands of NGS datasets and provide new analytic workflows for pathway analysis, differential expression, and machine learning models for responsive patient populations.
Ferroptosis is a form of cell death that can be selectively activated in sarcomas. In a matter of months, we were able to analyze petabytes of data with our software and identify a lead compound with a 100nM EC50 in cell-based assays.Explore Our Pipeline
Have questions? Interested in partnering with Arpeggio? Let us know.